|
Delayed
Nasdaq
13:01:43 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 1.465 USD | +3.90% |
|
+3.90% | +11.83% |
| 10-12 | MediciNova Phase 2 Trial in Fatty Liver Disease Drug Misses Primary Endpoints | MT |
| 10-12 | Medicinova, Inc. Provides Update on Mn-001 Phase 2 Clinical Trial Results and Mn-166 Combat-Als Trial | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.90% | +3.90% | -30.24% | +10.15% | +11.83% | +21.07% | -25.26% | -58.14% | -79.28% | 69.4M | |
| +0.65% | -3.56% | -12.32% | +14.23% | +57.11% | +33.53% | +60.50% | +5.04% | - | 63.48B | |
| +1.76% | +1.27% | -5.68% | +3.19% | +11.13% | +11.82% | +82.12% | +231.09% | +5,462.85% | 54.55B | |
| -0.94% | +0.99% | +7.81% | +12.42% | +17.11% | +10.45% | +102.18% | -17.00% | +234.11% | 53.59B | |
| +1.90% | -0.03% | +2.06% | +13.84% | +22.69% | +26.78% | +56.10% | +7.53% | +285.34% | 44.75B | |
| +2.31% | -3.27% | +1.86% | +13.12% | +23.04% | +17.98% | +100.32% | +2.53% | +1,016.88% | 41.62B | |
| +0.35% | -3.85% | -7.41% | +1.60% | +134.52% | +221.12% | +917.96% | +527.88% | - | 39.91B | |
| +0.64% | -3.85% | +6.99% | +6.21% | +10.10% | +11.71% | +45.57% | +5.41% | +152.66% | 32.47B | |
| +29.06% | +47.63% | +68.03% | +102.73% | +90.82% | +107.12% | +94.27% | +36.25% | +242.30% | 26.7B | |
| +3.72% | -7.45% | -12.60% | +19.81% | +47.33% | +24.25% | -2.99% | -60.58% | - | 23.36B | |
| +0.71% | -3.99% | -11.54% | -5.19% | -7.93% | -16.55% | -6.01% | -69.14% | - | 21.87B | |
| +1.97% | +2.86% | -17.80% | -7.11% | -44.42% | -41.48% | +306.43% | +226.90% | +614.40% | 20.74B | |
| +1.95% | +3.26% | +11.06% | +19.80% | +21.79% | +17.83% | +182.90% | +211.34% | +2,267.77% | 18.85B | |
| +4.47% | +8.35% | +26.84% | +55.41% | +87.32% | +98.83% | +127.12% | -14.84% | +391.66% | 17.13B | |
| +0.89% | +6.60% | +9.55% | +25.86% | +38.21% | +41.38% | +84.55% | -16.19% | +110.21% | 16.53B | |
| +1.00% | +1.70% | +12.51% | +16.22% | +49.84% | +63.88% | +224.48% | +201.82% | +503.63% | 16.19B | |
| +0.85% | +3.64% | +7.63% | -2.69% | - | - | - | - | - | 16.15B | |
| +0.84% | +3.90% | +3.90% | +0.42% | +183.22% | +163.59% | +345.61% | +1,418.19% | +787.21% | 15.21B | |
| -4.32% | -7.35% | -7.15% | -15.56% | +10.56% | +0.93% | +463.48% | - | - | 13.81B | |
| +11.92% | +9.75% | +15.81% | +12.81% | +11.58% | +14.40% | -14.62% | -29.02% | +153.14% | 14.12B | |
| Average | +3.18% | +1.85% | +3.47% | +14.86% | +40.83% | +43.61% | +165.51% | +144.95% | +867.35% | 27.55B | |
| Weighted average by Cap. | +2.70% | +0.90% | +3.01% | +14.63% | +40.56% | +43.26% | +167.08% | +123.44% | +1,243.82% |
- Stock Market
- Stocks
- MNOV Stock
- Sector MediciNova, Inc.
Select your edition
All financial news and data tailored to specific country editions
